KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Capital Expenditures (2016 - 2025)

Evolent Health has reported Capital Expenditures over the past 11 years, most recently at $7.8 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $7.8 million for Q4 2025, up 26.17% from a year ago — trailing twelve months through Dec 2025 was $34.1 million (up 36.94% YoY), and the annual figure for FY2025 was $34.1 million, up 36.94%.
  • Capital Expenditures for Q4 2025 was $7.8 million at Evolent Health, down from $9.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for EVH hit a ceiling of $10.7 million in Q4 2022 and a floor of $5.3 million in Q1 2024.
  • Median Capital Expenditures over the past 5 years was $7.2 million (2021), compared with a mean of $7.6 million.
  • Biggest five-year swings in Capital Expenditures: tumbled 44.59% in 2021 and later soared 65.79% in 2022.
  • Evolent Health's Capital Expenditures stood at $7.2 million in 2021, then skyrocketed by 48.3% to $10.7 million in 2022, then plummeted by 43.67% to $6.1 million in 2023, then increased by 1.64% to $6.2 million in 2024, then grew by 26.17% to $7.8 million in 2025.
  • The last three reported values for Capital Expenditures were $7.8 million (Q4 2025), $9.0 million (Q3 2025), and $8.8 million (Q2 2025) per Business Quant data.